Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 01 Nov 2023
The USA. S. On October 26, 2023, the Food and Drug Administration (FDA) approved mirikizumab, a highly effective new treatment for ulcerative colitis (UC), giving patients suffering from this chronic and crippling condition a new avenue to pursue.
Read Full NewsA nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.
Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.
1.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
2.
Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.
3.
Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain
4.
Report suggests a big improvement in lung cancer survival
5.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
1.
Clinical Analysis of Prostate Cancer
2.
All You Need to Know About Mesna: The Ultimate Guide
3.
The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025
4.
The Latest Research on Basal Cell Carcinoma: New Developments in Diagnosis and Cure
5.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge